Douglas Pratt

807 total citations
14 papers, 591 citations indexed

About

Douglas Pratt is a scholar working on Epidemiology, Health and Infectious Diseases. According to data from OpenAlex, Douglas Pratt has authored 14 papers receiving a total of 591 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 5 papers in Health and 4 papers in Infectious Diseases. Recurrent topics in Douglas Pratt's work include Influenza Virus Research Studies (6 papers), Vaccine Coverage and Hesitancy (5 papers) and Respiratory viral infections research (3 papers). Douglas Pratt is often cited by papers focused on Influenza Virus Research Studies (6 papers), Vaccine Coverage and Hesitancy (5 papers) and Respiratory viral infections research (3 papers). Douglas Pratt collaborates with scholars based in United States, Canada and Spain. Douglas Pratt's co-authors include Yun Lu, Jeffrey A. Kelman, Richard A. Forshee, Héctor S. Izurieta, Thomas MaCurdy, Michael Wernecke, Yoganand Chillarige, Yuqin Wei, Michael Lu and Wenjie Xu and has published in prestigious journals such as PEDIATRICS, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

Douglas Pratt

14 papers receiving 566 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Douglas Pratt United States	11	453	163	137	45	44	14	591
Xinghuo Pang China	13	357 0.8×	106 0.7×	108 0.8×	12 0.3×	42 1.0×	34	445
Masahiko Hachiya Japan	14	210 0.5×	158 1.0×	216 1.6×	14 0.3×	39 0.9×	51	537
Steve Black United States	14	313 0.7×	216 1.3×	129 0.9×	80 1.8×	44 1.0×	27	749
Robert Samuel United Kingdom	8	330 0.7×	95 0.6×	84 0.6×	8 0.2×	21 0.5×	15	467
Emily Simons United States	11	489 1.1×	183 1.1×	369 2.7×	27 0.6×	134 3.0×	17	743
Justin Carrico United States	10	191 0.4×	75 0.5×	98 0.7×	13 0.3×	19 0.4×	32	292
Sandra E. Talbird United States	14	270 0.6×	127 0.8×	129 0.9×	6 0.1×	20 0.5×	52	442
B C Ciancio Sweden	16	711 1.6×	291 1.8×	176 1.3×	42 0.9×	46 1.0×	24	1.0k
Luca Demattè Italy	10	395 0.9×	94 0.6×	214 1.6×	18 0.4×	19 0.4×	17	604
Dorothea Matysiak‐Klose Germany	12	243 0.5×	90 0.6×	111 0.8×	7 0.2×	43 1.0×	32	347

Countries citing papers authored by Douglas Pratt

Since Specialization

Citations

This map shows the geographic impact of Douglas Pratt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas Pratt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas Pratt more than expected).

Fields of papers citing papers by Douglas Pratt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas Pratt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas Pratt. The network helps show where Douglas Pratt may publish in the future.

Co-authorship network of co-authors of Douglas Pratt

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas Pratt. A scholar is included among the top collaborators of Douglas Pratt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas Pratt. Douglas Pratt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Pratt, Douglas, et al.. (2020). Molecular dynamics simulations of nanoindentation – the importance of force field choice on the predicted elastic modulus of FCC aluminum. Molecular Simulation. 46(12). 923–931. 5 indexed citations

Izurieta, Héctor S., David J. Graham, Mao Hu, et al.. (2020). Natural History of Coronavirus Disease 2019: Risk Factors for Hospitalizations and Deaths Among >26 Million US Medicare Beneficiaries. The Journal of Infectious Diseases. 223(6). 945–956. 46 indexed citations

Izurieta, Héctor S., Yoganand Chillarige, Jeffrey A. Kelman, et al.. (2020). Relative Effectiveness of Influenza Vaccines Among the United States Elderly, 2018–2019. The Journal of Infectious Diseases. 222(2). 278–287. 67 indexed citations

Izurieta, Héctor S., Michael Lu, Jeffrey A. Kelman, et al.. (2020). Comparative Effectiveness of Influenza Vaccines Among US Medicare Beneficiaries Ages 65 Years and Older During the 2019–2020 Season. Clinical Infectious Diseases. 73(11). e4251–e4259. 65 indexed citations

Ramanathan, Roshan, et al.. (2019). Use of controlled human infection models (CHIMs) to support vaccine development: US regulatory considerations. Vaccine. 37(31). 4256–4261. 14 indexed citations

Izurieta, Héctor S., Yun Lu, Yoganand Chillarige, et al.. (2019). Zostavax vaccine effectiveness among US elderly using real‐world evidence: Addressing unmeasured confounders by using multiple imputation after linking beneficiary surveys with Medicare claims. Pharmacoepidemiology and Drug Safety. 28(7). 993–1001. 12 indexed citations

Meissner, H. Cody, Karen M. Farizo, Douglas Pratt, Larry K. Pickering, & Amanda Cohn. (2018). Understanding FDA-Approved Labeling and CDC Recommendations for Use of Vaccines. PEDIATRICS. 142(3). 9 indexed citations

Izurieta, Héctor S., Yoganand Chillarige, Jeffrey A. Kelman, et al.. (2018). Statin Use and Risks of Influenza-Related Outcomes Among Older Adults Receiving Standard-Dose or High-Dose Influenza Vaccines Through Medicare During 2010–2015. Clinical Infectious Diseases. 67(3). 378–387. 16 indexed citations

Izurieta, Héctor S., Yoganand Chillarige, Jeffrey A. Kelman, et al.. (2018). Relative Effectiveness of Cell-Cultured and Egg-Based Influenza Vaccines Among Elderly Persons in the United States, 2017–2018. The Journal of Infectious Diseases. 220(8). 1255–1264. 125 indexed citations

10.

Chattopadhyay, Rana & Douglas Pratt. (2017). Role of controlled human malaria infection (CHMI) in malaria vaccine development: A U.S. food & drug administration (FDA) perspective. Vaccine. 35(21). 2767–2769. 10 indexed citations

11.

Izurieta, Héctor S., Michael Wernecke, Jeffrey A. Kelman, et al.. (2016). Effectiveness and Duration of Protection Provided by the Live-attenuated Herpes Zoster Vaccine in the Medicare Population Ages 65 Years and Older. Clinical Infectious Diseases. 64(6). 785–793. 67 indexed citations

12.

Izurieta, Héctor S., Nicole N. Thadani, David K. Shay, et al.. (2015). Comparative effectiveness of high-dose versus standard-dose influenza vaccines in US residents aged 65 years and older from 2012 to 2013 using Medicare data: a retrospective cohort analysis. The Lancet Infectious Diseases. 15(3). 293–300. 130 indexed citations

13.

Hayward, John J., et al.. (2013). Inclusion chemistry of a thiazyl radical in zeolite-Y. Dalton Transactions. 43(3). 1332–1337. 11 indexed citations

14.

Beldjoudi, Yassine, et al.. (2012). Preparation and crystal structures of the isomeric series 4-tolyl-1,2,3,5-dithiadiazolyl, (o-MeC₆H₄CNSSN)₂, (m-MeC₆H₄CNSSN)₂and (p-MeC₆H₄CNSSN)₂. CrystEngComm. 15(6). 1107–1113. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact